Synthesis and antitumor activity of optically active thiourea and their 2-aminobenzothiazole derivatives: a novel class of anticancer agents.

Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer.

Should molecular technology replace urine cytology?

Expression of kallikrein 7 diminishes pancreatic cancer cell adhesion to vitronectin and enhances urokinase-type plasminogen activator receptor shedding.

Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells.

The extracellular matrix protein fibronectin is a substrate for kallikrein 7.

Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.

Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival.

Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.

Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin.

The natural history of postoperative renal function in patients undergoing ileal conduit diversion for cancer measured using serial isotopic glomerular filtration rate and 99m technetium-mercaptoacetyltriglycine renography.

Weekly fluorouracil at 425 mg/m(2) plus low-dose folinic acid for 24 weeks as adjuvant treatment for colorectal cancer: assessment of toxicity and delivery.

Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.

Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy.

Extra-adrenal pheochromocytoma: an unusual cause of deep vein thrombosis.